BARCELONA, Spain, July 29, 2015 /PRNewswire/ --
Veeva CRM's native support for Windows 10 provides single-device choice for life sciences companies
Veeva Systems' latest release of Veeva CRM Mobile this month will natively support Microsoft Windows 10. Through its partnership with Microsoft, Veeva developed Veeva CRM for Windows 10 ahead of Microsoft's July 29 release, ensuring customers can fully leverage the new operating system as soon as it is available.
Veeva's underlying multitenant cloud architecture allows for this type of continuous innovation and rapid time to value. And the company's industry cloud focus ensures its solutions are tailored to fit life sciences' unique needs and regulatory requirements.
"With technologies and markets changing at an incredible pace, Veeva has always allowed Depomed to stay a step ahead," said Mark Howard, senior director of IT at Depomed. Depomed's field sales reps have been leveraging Veeva CRM Mobile for Windows 8 since introduced in 2013. "With Veeva, we are not responsible for shouldering either the cost or resources tied to supporting new platforms and upgrades. Veeva is evolving with our growing business as new and enhanced capabilities allow our teams in the field to make accurate and efficient decisions time after time."
Native support for Windows 10 will provide an enhanced user experience. Veeva CRM Approved Email, for instance, will get a boost from Windows 10's new dictation-driven email capability. Meanwhile, applications like Veeva CRM Engage and Veeva CRM CoBrowse will benefit from animation upgrades that will improve eDetailing sessions with physicians.
"We are excited Veeva is proactively supporting Windows 10, allowing our joint customers to be among the first to move to our new operating system," said Craig Dewar, senior director of product marketing for Windows at Microsoft. "Veeva CRM combined with Windows tablets enable life sciences sales reps to be productive and secure on a single, mobile device."
Veeva first introduced its Windows 8, touchscreen-optimised Veeva CRM Mobile solution in 2013 to provide life sciences companies with the freedom to choose among a range of tablets. "We are committed to optimising Veeva CRM for key mobile devices and platforms so our customers have the choice to use the technology that works best for their needs," said Brian Longo, general manager of commercial products at Veeva. "Now, Veeva CRM runs on the latest operating systems for both Apple and Windows."
The latest release of Veeva CRM with Windows 10 support is now available to customers.
• For more on Veeva CRM, please visit: veeva.com/crm
• Stay updated on the latest Veeva news on LinkedIn: http://www.linkedin.com/company/veeva-systems
• Follow @veevasystems on Twitter: http://www.twitter.com/veevasystems
• Like Veeva on Facebook: http://www.facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 275 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit http://www.veeva.com.
This release contains forward-looking statements, including the future availability of Veeva products and related third party integrations, market demand for and acceptance of Veeva's products and services, the results from use of Veeva's products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva's historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva's expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva's financial results are included under the captions, "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's filing on Form 10-Q for the period ended April 30, 2015. This is available on the company's website at http://www.veeva.com under the Investors section and on the SEC's website at http://www.sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.
SOURCE Veeva Systems